NO991700L - Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer - Google Patents

Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer

Info

Publication number
NO991700L
NO991700L NO991700A NO991700A NO991700L NO 991700 L NO991700 L NO 991700L NO 991700 A NO991700 A NO 991700A NO 991700 A NO991700 A NO 991700A NO 991700 L NO991700 L NO 991700L
Authority
NO
Norway
Prior art keywords
viral infections
benzimidazole
carbamates
cancer
treatment
Prior art date
Application number
NO991700A
Other languages
English (en)
Other versions
NO991700D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO991700D0 publication Critical patent/NO991700D0/no
Publication of NO991700L publication Critical patent/NO991700L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk preparat som inhiberer veksten av tumorer og cancere i pattedyr og som kan anvendes for å behandle virus- infeksjoner som omfatter et fungicid. Det spesielle fungicid som anvendes er et benzimidazolderivat med formel (I), hvor R er valgt fra gruppen bestående av H, karboksyl, (-CO2H), hydroksyl, amino eller estere (-CO2R'), hvor R1 er valgt fra gruppen bestående av alkoksy, haloalkyl, alkenyl og cykloalkyl, hvor alkylgruppene har fra l til 8 karbonatomer eller CH3CH2(OCH2CH2) n_ eller CH3CH2CH2-(OCH2CH2CH2) n_ eller (CH3)2CH-(OCH(CH3)CH2)n_hvor n er fra l til 3, de farmasøy- tisk akseptable salter derav, eller blandinger derav.
NO991700A 1997-05-16 1999-04-09 Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer NO991700L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/857,811 US6506783B1 (en) 1997-05-16 1997-05-16 Cancer treatments and pharmaceutical compositions therefor
PCT/US1997/021565 WO1998051304A1 (en) 1997-05-16 1997-11-26 Benzimidazole-2-carbamates for the treatment of viral infections and cancer

Publications (2)

Publication Number Publication Date
NO991700D0 NO991700D0 (no) 1999-04-09
NO991700L true NO991700L (no) 2000-01-13

Family

ID=25326784

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991700A NO991700L (no) 1997-05-16 1999-04-09 Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer

Country Status (22)

Country Link
US (13) US6506783B1 (no)
EP (1) EP0956017B1 (no)
JP (1) JP2001527523A (no)
KR (1) KR20000049065A (no)
CN (1) CN1254282A (no)
AR (1) AR010008A1 (no)
AT (1) ATE363904T1 (no)
AU (1) AU728690B2 (no)
BR (1) BR9714634A (no)
CA (1) CA2268840C (no)
CZ (1) CZ125299A3 (no)
DE (1) DE69737793D1 (no)
HU (1) HUP0001170A3 (no)
IL (1) IL129352A0 (no)
NO (1) NO991700L (no)
NZ (1) NZ335159A (no)
PE (1) PE11099A1 (no)
PL (1) PL335541A1 (no)
SK (1) SK47099A3 (no)
TR (1) TR199901528T2 (no)
WO (1) WO1998051304A1 (no)
ZA (1) ZA979096B (no)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
WO2002045688A2 (en) * 2000-12-07 2002-06-13 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
US7423015B1 (en) 2001-01-11 2008-09-09 Board Of Regents, The University Of Texas System Antihelminthic drugs as a treatment for hyperproliferative diseases
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
AUPR626001A0 (en) * 2001-07-10 2001-08-02 Mcgregor, Neil A method of treatment and/or prophylaxis
CA2461227C (en) * 2001-09-24 2012-05-15 Jessie L.-S Au Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
WO2003082273A1 (en) * 2002-03-26 2003-10-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
US8492443B2 (en) * 2002-07-08 2013-07-23 Joe S. Wilkins, Jr. Treatment for herpes simplex virus and other infectious diseases
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
KR20050122210A (ko) * 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
EP1598353A1 (en) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
US8138342B2 (en) * 2004-10-12 2012-03-20 High Point Pharmacueticals, LLC 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
US7193254B2 (en) * 2004-11-30 2007-03-20 International Business Machines Corporation Structure and method of applying stresses to PFET and NFET transistor channels for improved performance
JP2008522984A (ja) * 2004-12-06 2008-07-03 ニューサウス イノベイションズ ピーティーワイ リミテッド 癌の処置
JP2008528643A (ja) 2005-02-04 2008-07-31 スルバック アーぺーエス サバイビンペプチドワクチン
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria
KR20080076916A (ko) * 2005-11-01 2008-08-20 트랜스테크 파르마, 인크. 치환된 아미드의 약학적 사용
JP2009513611A (ja) * 2005-11-01 2009-04-02 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 置換アミドの医薬用途
CA2883060C (en) * 2005-11-09 2019-01-08 Philera New Zealand Limited Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits
CA2642813A1 (en) * 2006-02-28 2007-09-07 Merck & Co., Inc. Inhibitors of histone deacetylase
EP2007722A1 (en) * 2006-03-21 2008-12-31 High Point Pharmaceuticals, LLC Adamantane derivatives for the treatment of the metabolic syndrome
KR20090014347A (ko) 2006-04-07 2009-02-10 하이 포인트 파마슈티칼스, 엘엘씨 11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
US20100003679A1 (en) * 2006-06-09 2010-01-07 University Of Miami Assessment of cellular composition and fractional viability and uses thereof
JP2009539937A (ja) * 2006-06-16 2009-11-19 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 置換型ピペリジンカルボキサミドの医薬的使用
US8048908B2 (en) * 2006-07-13 2011-11-01 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
EP1878721A1 (en) * 2006-07-13 2008-01-16 Novo Nordisk A/S 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
US8334305B2 (en) * 2007-02-23 2012-12-18 High Point Pharmaceuticals, Llc N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
WO2008101885A1 (en) * 2007-02-23 2008-08-28 High Point Pharmaceuticals, Llc N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
CA2675669C (en) * 2007-02-23 2015-05-26 High Point Pharmaceuticals, Llc Novel compounds
EP2125704A1 (en) * 2007-02-23 2009-12-02 High Point Pharmaceuticals, LLC N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
CN101652359A (zh) * 2007-03-09 2010-02-17 高点制药有限责任公司 作为羟类固醇脱氢酶抑制剂的吲哚-和苯并咪唑酰胺类
CA2681934A1 (en) * 2007-03-28 2008-10-02 High Point Pharmaceuticals, Llc 11beta-hsd1 active compounds
WO2008127924A1 (en) * 2007-04-11 2008-10-23 High Point Pharmaceuticals, Llc. Novel compounds
US8383683B2 (en) * 2007-04-24 2013-02-26 High Point Pharmaceuticals, Llc Pharmaceutical use of substituted amides
US8461189B2 (en) * 2007-06-27 2013-06-11 Merck Sharp & Dohme Corp. Pyridyl derivatives as histone deacetylase inhibitors
AU2008269154B2 (en) 2007-06-27 2014-06-12 Merck Sharp & Dohme Llc 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
US8513430B2 (en) 2010-07-27 2013-08-20 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
AR091006A1 (es) 2012-05-09 2014-12-30 Univ Western Health Sciences Formulaciones de testosterona proliposomal
US9649313B2 (en) * 2012-11-26 2017-05-16 The University Of North Carolina At Chapel Hill Use of ITK inhibitors for the treatment of cancer
WO2016077648A1 (en) * 2014-11-11 2016-05-19 Neymeyer Calvin E Method of treating pre-cancerous lesion with glyphosate, and compositions thereof
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
WO2018081361A1 (en) * 2016-10-28 2018-05-03 Children's Hospital Medical Center Methods and compositions for treatment of myelodyspastic syndromes and/or acute myleoid leukemias
CN109633026A (zh) * 2019-01-03 2019-04-16 上海市农业科学院 一种液相色谱-串联质谱检测多菌灵及其代谢物的方法
EP3907230B1 (en) 2020-03-30 2024-08-28 Biometrix Technology Inc. Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
JP7376108B2 (ja) 2020-06-23 2023-11-08 バイオメトリックス テクノロジーズ インコーポレイテッド 新規なベンズイミダゾール誘導体、その製造方法及びその抗癌剤または抗ウイルス剤としての用途
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE158398C (no)
DE136499C (no)
US2933502A (en) 1958-02-12 1960-04-19 Du Pont Benzimidazolone derivatives
US3010968A (en) 1959-11-25 1961-11-28 Du Pont Process for manufacture of certain alkyl esters of benzimidazole carbamic acids
NL134354C (no) 1963-05-23
US3499761A (en) 1964-07-20 1970-03-10 Gaf Corp Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents
BE666795A (no) 1964-08-04 1966-01-13
USRE28403E (en) 1964-08-04 1975-04-29 Butyl and n-propoxy-z-carbo- methoxyaminobenzimidazoles
US3541213A (en) 1966-05-06 1970-11-17 Du Pont Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles
US3399212A (en) 1966-05-16 1968-08-27 Smith Kline French Lab Benzimidazole ureas
US3480642A (en) 1967-03-22 1969-11-25 Smithkline Corp Process for producing 2-carbalkoxyaminobenzimidazoles
US3881014A (en) 1968-11-05 1975-04-29 Bayer Ag N-tritylimidazoles for treating fungal infections
BE744970A (fr) 1969-01-28 1970-07-27 Lilly Co Eli Agents antiviraux et immuno-depresseurs
BE759337A (fr) 1969-11-24 1971-05-24 Lilly Co Eli Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones
FR2046114A5 (en) 1970-01-30 1971-03-05 Dynachim Sarl Benzimidazole derivs anthelmintic, antifung - al bactericidal, aericidal, insecticidal, nema
US3956262A (en) 1970-12-09 1976-05-11 Beecham Group Limited Triazenoimidazoles
US3738995A (en) 1971-05-14 1973-06-12 Du Pont Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates
DE2144505A1 (de) 1971-09-06 1973-03-15 Boehringer Sohn Ingelheim S-triazino- eckige klammer auf 1,2-a eckige klammer zu-benzimidazole
FR2155888A1 (en) 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants
DE2227919C2 (de) 1972-06-08 1982-12-23 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Benzimidazol-2-yl-carbaminsäure-methylester
DE2253324A1 (de) 1972-10-31 1974-05-09 Bayer Ag 1-alkoxycarbonyl-2- eckige klammer auf bis-(alkoxycarbonyl)-amino eckige klammer zu -benzimidazole, verfahren zu ihrer herstellung, sowie ihre verwendung als fungizide
US4046906A (en) 1973-04-21 1977-09-06 Hoechst Aktiengesellschaft Salts of alkyl 2-benzimidazole-carbamate
JPS5142565A (en) 1974-10-09 1976-04-10 Copal Co Ltd onnoff taimaa
US4001423A (en) 1975-06-20 1977-01-04 Dodds Dale I 2-(2-ethoxy)ethoxyethyl benzimidazolecarbamate
DE2527677A1 (de) 1975-06-21 1977-01-20 Bayer Ag Verfahren zur herstellung von 2,4- dioxo-1,2,3,4-tetrahydro-s-triazino- eckige klammer auf 1,2-a eckige klammer zu -benzimidazolen
US4086235A (en) 1976-04-12 1978-04-25 Syntex (U.S.A.) Inc. 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
IN159210B (no) 1982-01-11 1987-04-11 Council Scient Ind Res
IN158878B (no) 1982-07-15 1987-02-07 Council Scient Ind Res
HU193951B (en) 1985-03-11 1987-12-28 Richter Gedeon Vegyeszet Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
US4731366A (en) 1986-08-05 1988-03-15 Harbor Branch Oceanographic Institution, Inc. Discorhabdin compositions and their methods of use
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
US5329012A (en) 1987-10-29 1994-07-12 The Research Foundation Of State University Of New York Bis(acyloxmethyl)imidazole compounds
US5114951A (en) 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5149527A (en) 1990-09-18 1992-09-22 Oncotech, Inc. Immunopotentiating protocol for chemotherapy-responsive tumors
US5284662A (en) 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
JPH04223274A (ja) 1990-12-26 1992-08-13 Kansei Corp 加速度センサ
GB9106278D0 (en) 1991-03-25 1991-05-08 Smithkline Beecham Plc Method of treatment
US5310748A (en) 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5290801A (en) 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
KR950702994A (ko) 1992-08-12 1995-08-23 로렌스 티. 웰츠 탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
FR2703057B1 (fr) 1993-03-24 1995-06-16 Elysees Balzac Financiere Matériau alvéolaire cellulosique renfermant un agent biocide et procédé pour sa préparation.
RU2139052C1 (ru) 1993-03-31 1999-10-10 Мерк Энд Ко., Инк. Комбинация ингибитора вич-протеазы с другими антивирусными соединениями, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
US5434163A (en) 1993-05-14 1995-07-18 The Medical College Of Pennsylvania Treatment of Cryptococcus neoformans infection
US5554373A (en) 1993-11-05 1996-09-10 Seabrook; Samuel G. Compositions containing anti-microbial agents and methods for making and using same
JP3213471B2 (ja) 1994-04-13 2001-10-02 ポーラ化成工業株式会社 薬効成分含有リポソーム製剤の製造方法
ZA962880B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5629341A (en) 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US6262093B1 (en) * 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
EP0820281B1 (en) 1995-04-12 2007-07-25 UAF Technologies and Research, LLC A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en) 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections
US5665751A (en) 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
MX9707809A (es) * 1995-06-07 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
US6200992B1 (en) 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US20010039291A1 (en) 1995-06-07 2001-11-08 The Procter & Gamble Company Compositions and methods of treatment for cancer or viral infections
SK168697A3 (en) 1995-06-07 1998-12-02 Procter & Gamble A medicament for the treatment of leukemia
TR199800244T2 (xx) 1995-08-03 1998-09-21 The Procter & Gamble Company Griseofulvinin, kanserlerin ilerlemesini �nlemede kullan�m�.
MX9707808A (es) 1995-08-04 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5908855A (en) 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
PL324904A1 (en) 1995-08-04 1998-06-22 Procter & Gamble Application of fluconazole in carcinoma development inhibition
WO1997012613A1 (en) 1995-10-05 1997-04-10 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US5627094A (en) * 1995-12-04 1997-05-06 Chartered Semiconductor Manufacturing Pte, Ltd. Stacked container capacitor using chemical mechanical polishing
US6541213B1 (en) * 1996-03-29 2003-04-01 University Of Washington Microscale diffusion immunoassay
DE19623226A1 (de) * 1996-06-11 1997-12-18 Basf Ag Katalysatorsysteme vom Typ der Ziegler-Natta-Katalysatoren
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US5825811A (en) 1997-01-16 1998-10-20 Motorola, Inc. Method and apparatus for facilitating inbound channel access
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US5908885A (en) * 1997-07-01 1999-06-01 University Of South Alabama Polysuccinimide and polyaspartate as additives to cementitious materials
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DE19842116C2 (de) 1998-09-07 2001-02-08 Schuelke & Mayr Gmbh Verwendung von Derivaten von Methylenbisoxazolidin und dadurch erhaltene Zusammensetzungen
US6248843B1 (en) * 1998-09-18 2001-06-19 Mcwhorter Technologies, Inc. Powder coatings based on branched oligoesters and triazole blocked polyisocyanates
ES2326502T3 (es) 1998-10-09 2009-10-13 General Mills, Inc. Encapsulacion de componentes liquidos sensibles en una matriz para obtener particulas discretas de larga conservacion.
US6211177B1 (en) 1998-11-24 2001-04-03 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
US20010053773A1 (en) 1998-12-22 2001-12-20 The Procter & Gamble Company Method for inhibiting the growth of cancers
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6135835A (en) * 1999-08-16 2000-10-24 Future Beach Corporation Aquatic vehicle
WO2001083457A2 (en) 2000-04-28 2001-11-08 The Procter & Gamble Company Benzimidazole-2-carbamates and their use in cancer treatment
US6384049B1 (en) 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6290929B1 (en) 2000-07-28 2001-09-18 The Procter & Gamble Company Cancer treatment
US6518269B1 (en) 2000-07-28 2003-02-11 University Of Arizona Foundation Cancer treatment
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
JP2004509949A (ja) 2000-09-26 2004-04-02 ザ　ユニバーシティ　オブ　アリゾナ　ファウンデーション 化合物および癌またはウイルス性感染症治療におけるその使用方法
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
WO2002041891A2 (en) 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles

Also Published As

Publication number Publication date
AU728690B2 (en) 2001-01-18
EP0956017B1 (en) 2007-06-06
US20050119236A1 (en) 2005-06-02
CZ125299A3 (cs) 1999-09-15
SK47099A3 (en) 2000-05-16
CA2268840C (en) 2006-10-03
EP0956017A1 (en) 1999-11-17
US20050288349A1 (en) 2005-12-29
KR20000049065A (ko) 2000-07-25
PL335541A1 (en) 2000-04-25
HUP0001170A3 (en) 2001-07-30
IL129352A0 (en) 2000-02-17
NZ335159A (en) 2001-09-28
US6710065B1 (en) 2004-03-23
PE11099A1 (es) 1999-03-01
HUP0001170A2 (hu) 2001-05-28
US6900235B1 (en) 2005-05-31
CN1254282A (zh) 2000-05-24
AU7402798A (en) 1998-12-08
WO1998051304A1 (en) 1998-11-19
US6420411B1 (en) 2002-07-16
US6482843B1 (en) 2002-11-19
TR199901528T2 (xx) 1999-09-21
ATE363904T1 (de) 2007-06-15
US6506783B1 (en) 2003-01-14
BR9714634A (pt) 2000-05-23
ZA979096B (en) 1998-08-28
US6423735B1 (en) 2002-07-23
CA2268840A1 (en) 1998-11-19
AR010008A1 (es) 2000-05-17
US6864275B1 (en) 2005-03-08
US6984654B2 (en) 2006-01-10
DE69737793D1 (de) 2007-07-19
US6407131B1 (en) 2002-06-18
JP2001527523A (ja) 2001-12-25
US20050192328A1 (en) 2005-09-01
US6423736B1 (en) 2002-07-23
US6077862A (en) 2000-06-20
NO991700D0 (no) 1999-04-09

Similar Documents

Publication Publication Date Title
CA2268840A1 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
AP1895A (en) Novel benzoimidazole derivatives useful as antiproliferative agents.
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
WO2001056989A3 (en) Inhibitors of factor xa
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
ATE412659T1 (de) Tubulysine, herstellungsverfahren und tubulysin- mittel
LU91761I2 (fr) Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®)
EP0941998A3 (en) 3,6-ketal and enol ether macrolide antibiotics
EA200100983A1 (ru) Производные 13-метилэритромицина
FR2741619B1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
DK0992509T3 (da) Nye makrolid-derivater
DK0984019T3 (da) C11-carbamater fra antibakterielle macrolider
KR910016915A (ko) 과콜레스테롤혈증 치료제
IS5588A (is) Æxliseyðandi miðlar
NO20002099L (no) 6,11-bro-erytromycinderivater
RU94037246A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща
DE69012560D1 (de) Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.
MXPA05008706A (es) 4-[(2, 4- dicloro-5 -metoxifenil) amino]-6 -alcoxi -3- quinolincarbonitrilos para tratamiento de lesiones isquemicas.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
NO20020804L (no) Nye A-500359-derivater
BR0107282A (pt) Composto, composição farmacêutica e métodos para prevenir ou tratar uma condição em um mamìfero e para inibir a coagulação de amostras biológicas
AP9801235A0 (en) Erythromycin derivatives.
EA200200292A1 (ru) Производные гигромицина
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
NO20005551L (no) 2"-deoksyhygromycinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application